Sangamo Therapeutics, Inc. · NASDAQ:SGMO

Armistice Capital, LLC reported a 9.75% stake in Sangamo Therapeutics, Inc. (Schedule 13G)

Event Mar 31, 2026 · Filed May 15, 2026

Armistice Capital, LLC reported a 9.75% stake in Sangamo Therapeutics, Inc., 40,400,067 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G).

Stake
9.75%
Shares
40,400,067
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Armistice Capital, LLC9.75%40,400,067
Steven Boyd9.75%40,400,067

Source

View original at SEC

Related